R R Kabel Limited (NSE:RRKABEL)

Sage Therapeutics Revenue

R R Kabel had revenue of 20.59B INR in the quarter ending June 30, 2025, with 13.85% growth. This brings the company's revenue in the last twelve months to 78.69B, up 15.63% year-over-year. In the fiscal year ending March 31, 2025, R R Kabel had annual revenue of 76.18B with 15.52% growth.

• Revenue (ttm): 78.69B
• Revenue Growth: +15.63%
• P/S Ratio: 1.80
• Revenue / Employee: 21.39M
• Employees: 3,678
• Market Cap: 141.76B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	76.18B	10.24B	15.52%
Mar 31, 2024	65.95B	9.95B	17.78%
Mar 31, 2023	55.99B	12.13B	27.66%
Mar 31, 2022	43.86B	16.62B	61.01%
Mar 31, 2021	27.24B	2.45B	9.90%